Conflict of Interest
Nordisk, and Sanofi.
ONCOLOGY, BRADLEY
Marc Bonaca has received grant support for Brigham and Women’s Hospital from Pfizer and grant support for CPC Clinical Research from Amgen, AstraZeneca, Bayer, Janssen, Novo Nordisk, and Sanofi. Javid J. Moslehi has served on advisory boards for Amgen, AstraZeneca, Audentes, Bristol Myers Squibb, Boston Biomedical, Cytokinetics, Deciphera, Immunocore, Ipsen, Janssen, Myovant, Pfizer, Regeneron, Takeda, and Triple-Gene/Precigen and is supported by the National Institute of Health (R01HL141466, R01HL155990, R01HL156021). Jonathan A. Ledermann reports serving as a consultant or advisor for Artios Pharma, AstraZeneca, Bristol Myers Squibb, Clovis Oncology, Eisai, GSK, Immagene, Miltenyni, MSD, Novocure, Nuvation, and Pfizer; has received research funding from AstraZeneca and MSD; has received honoraria from AstraZeneca, Clovis Oncology, Eisai, and GSK; and has other relationships with Mersana and Sutro Bio. Elisabete Michelon is an employee of and holds stocks in Pfizer. Caimiao Wei is an employee of and holds stock in Pfizer. Michael Moran was an employee of Pfizer Pharma GmbH at the time the study was conducted and is currently an employee of AbbVie Deutschland GmbH & Co KG; has stock or other ownership in Pfizer and AbbVie; and has received travel, ­accommodations, or expenses from Pfizer. Bradley J. Monk reports serving as a consultant or advisor for and has received honoraria from Agenus, Akeso Bio, Aravive, AstraZeneca, Clovis Oncology, Eisai, Elevar Therapeutics, Genmab/Seagen, GOG Foundation, Gradalis, ImmunoGen, Iovance, Karyopharm, Mersana Therapeutics, MSD, Myriad Pharmaceuticals, Novocure, Pfizer, Puma Biotechnology, Roche/Genentech, Tesaro/GSK, and VBL Therapeutics; is a member of a speakers bureau for AstraZeneca, Clovis Oncology, Eisai, MSD, Roche/Genentech, and Tesaro/GSK; and reports employment at McKesson/US Oncology. Eric Pujade-Lauraine reports personal fees from AstraZeneca, Clovis Oncology, Incyte, Pfizer, Roche, and Tesaro; nonfinancial support from AstraZeneca, Roche, and Tesaro; and is the chair of ARCAGY Research.